CO-LOCATED EVENTS
NextPrevious

Session

(2) Icebreaker

Sunday, March 16

08:00 PM - 10:00 PM

Live in Everett

Less Details

  • What specific challenges have been encountered with traditional MES since their launch, and how do these issues impact operational efficiency?
  • How does a system-agnostic approach enhance the adaptability and scalability of next-generation MES for gene companies?
  • What key features should be prioritized in next-generation MES to ensure alignment with the operational goals of gene companies and improve overall productivity?
Workshop

Speaker

Zack Gendron

Associate Director Automation, ElevateBio, LLC

Zack is Associate Director of Automation Information Systems with over 15 years of experience in the biotechnology and pharmaceutical industries, specializing in automation engineering and process optimization. He has a proven track record in implementing advanced automation solutions for clinical trial manufacturing, particularly using technologies like DeltaV and Rockwell FactoryTalk.
With expertise in integrating state-of-the-art instruments and exploring augmented reality solutions, Zack is committed to driving innovation in biotech manufacturing. His collaborative approach and focus on operational excellence position him as a key contributor in enhancing manufacturing efficiency and reliability.

Company

ElevateBio, LLC

ElevateBio is a technology-driven company built to power the development of transformative cell and gene therapies today and for many decades to come. The company has assembled industry-leading talent, built state-of-the-art facilities, and integrated diverse technology platforms, including gene editing, induced pluripotent stem cells (iPSCs), and protein, vector, and cellular engineering, necessary to drive innovation and commercialization of cellular and genetic medicines. In addition, ElevateBio BaseCamp is a purpose-built, technology-enabled manufacturing platform offering process innovation, process sciences, and current Good Manufacturing Practice (cGMP) manufacturing capabilities for viral vectors, RNA, and cell therapy production. Through BaseCamp, its expanding footprint, and its next-generation enabling technologies, ElevateBio is rapidly growing its collaborations with industry partners while also selectively developing its own portfolio of cellular and genetic medicines. ElevateBio's team of scientists, drug developers, and company builders are redefining what it means to be a technology company in the world of drug development, blurring the line between technology and healthcare.

NextPrevious